title: [Organizational characteristics of treatment for chronic hepatitis in Hungary: Hepatitis Registry and Priority Index].
abstract: Hepatitis Registry was developed by the Hepatology Section of the Hungarian Gastroenterology Society with the contribution of the Foundation for Liver Patients. The main task was to register all interferon based treatments of chronic hepatitis C and B and to facilitate the preauthorization process. The registry helped to clarify the number and characteristics of hepatitis C patients waiting for triple therapy; 3000 previously failed patients are still eligible for protease inhibitor therapy, 40% of them already developed cirrhosis stage and 40% are null responders to the previous therapy. As a file is created for treatment authorization, the system counts automatically the Priority Index according to the calculation set in the guideline. Priority Index reflects the urgency of treatment. The most prominent parameter of the Index is the degree of fibrosis, but it also takes into account the progression rate, prognostic factors, and special situations.
authors.affiliation: Egyesített Szent István és Szent László Kórház Budapest. michael@makara.md
authors.forename: Mihály
authors.initials: M
authors.lastname: Makara
authors.forename: Gábor
authors.initials: G
authors.lastname: Horváth
authors.forename: Ferenc
authors.initials: F
authors.lastname: Szalay
authors.forename: István
authors.initials: I
authors.lastname: Tornai
authors.forename: Béla
authors.initials: B
authors.lastname: Hunyady
mesh_terms: D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D003695:Delivery of Health Care / Q000458:organization & administration*; D004359:Drug Therapy, Combination; D006292:Health Priorities / Q000458:organization & administration / Q000592:standards / Q000639:trends; D006525:Hepatitis, Viral, Human / Q000188:drug therapy / Q000453:epidemiology / Q000628:therapy*; D006801:Humans; D006814:Hungary / Q000453:epidemiology; D007372:Interferons / Q000627:therapeutic use; D008103:Liver Cirrhosis / Q000517:prevention & control / Q000821:virology; D012042:Registries; D012254:Ribavirin / Q000627:therapeutic use; D018570:Risk Assessment; D012307:Risk Factors
chemical_list: D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons